【据《Eur J Intern Med》2014年7月报道】题:替诺福韦对于免疫抑制患者HBV再激活的预防及治疗作用。一项三级中心的真实研究(作者Koskinas JS等)乙型肝炎患者接受免疫抑制剂治疗期间如果发生病毒再激活,很容易发展为威胁生命的肝功能失代偿,因此预防和治疗很关键。至今仍没有关于替诺福韦在这方面作用的报道。因此,作者的研究目的是探讨接受免疫 [According to “Eur J Intern Med” July 2014] Title: Prevention and treatment effect of tenofovir on HBV reactivation in immunosuppressed patients. A true study of a tertiary center (authored by Koskinas JS et al.) Hepatitis B patients who develop viral reactivation during immunosuppressive therapy can easily develop life-threatening hepatic decompensation and prevention and treatment are therefore critical. To date, no reports of tenofovir effects in this regard have been reported. Therefore, the author's research goal is to explore immunization